Effect of clozapine on white matter integrity in patients with schizophrenia: A diffusion tensor imaging study

Psychiatry Research - Neuroimaging

Volumn 223, Issue 3, 2014, Pages 226-235

  Ozcelik Eroglu, Elcin ^a   Ertugrul, Aygun ^a   Oguz, Kader Karli ^a,b   Has, Arzu Ceylan ^b   Karahan, Sevilay ^a   Yazici, Mumin Kazim ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b BILKENT UNIVERSITY   (Turkey)

Author keywords

Clozapine; Diffusion tensor imaging; Fractional anisotropy; Schizophrenia; White matter

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DRUG EFFECT; EXPERIMENTAL COGNITIVE TEST; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MALE; MIDDLE CEREBELLAR PEDUNCLE; OCCIPITAL LOBE; PARIETAL LOBE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEMANTICS; WHITE MATTER;

CLOZAPINE; DIFFUSION TENSOR IMAGING; FRACTIONAL ANISOTROPY; SCHIZOPHRENIA; WHITE MATTER;

ADULT; ANISOTROPY; ANTIPSYCHOTIC AGENTS; BRAIN; CLOZAPINE; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA;

EID: 84905961072     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2014.06.001     Document Type: Article

References (87)

1. Anil A.E., Kivircik B., Batur S., Kabakci E., Kitis A., Guven E., Basar K., Turgut T.I., Arkar H. The Turkish version of the Auditory Consonant Trigram Test as a measure of working memory: a normative study. Clinical Neuropsychology 2003, 17:159-169.
2. Arango C., Breier A., McMahon R., Carpenter W.T., Buchanan R.W. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes. American Journal of Psychiatry 2003, 160:1421-1427.
3. Ardekani B.A., Nierenberg J., Hoptman M.J., Javitt D.C., Lim K.O. MRI study of white matter diffusion anisotropy in schizophrenia. NeuroReport 2003, 14:2025-2029.
4. Ashtari M., Cottone J., Ardekani B.A., Cervellione K., Szeszko P.R., Wu J., Chen S., Kumra S. Disruption of white matter integrity in the inferior longitudinal fasciculus in adolescents with schizophrenia as revealed by fiber tractography. Archives of General Psychiatry 2007, 64:1270-1280.
5. Assaf Y., Pasternak O. Diffusion tensor imaging based white matter mapping in brain research: a review. Journal of Molecular Neuroscience 2008, 34:51-61.
6. Bai O., Chlan-Fourney J., Bowen R., Keegan D., Li X.M. Expression of BDNF mRNA in rat hippocampus after treatment with antipsychotics drugs. Journal of Neuroscience Research 2003, 71:127-131.
7. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR in Biomedicine 2002, 15:435-455.
8. Benton A.L., Hamsher K. Multilingual Aphasia Examination: Manual of Instructions 1978, AJA Associates, Iowa City, IA.
9. Bramon E., Rabe-Hesketh S., Sham P., Murray R.M., Frangou S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophrenia Research 2004, 70:315-329.
10. Buchsbaum M.S., Schoenknecht P., Torosjan Y., Newmark R., Chu K.W., Mitelman S., Brickman A.M., Shihabuddin L., Haznedar M.M., Hazlett E.A., Ahmed S., Tang C. Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. Annals of General Psychiatry 2006, 28:5-19.
11. Buchsbaum M.S., Friedman J., Buchsbaum B.R., Chu K.W., Hazlett E.A., Newmark R., Schneiderman J.S., Torosjan Y., Tang C., Hof P.R., Stewart D., Davis K.L., Gorman J. Diffusion tensor imaging in schizophrenia. Biological Psychiatry 2006, 60:1181-1187.
12. Buchsbaum M.S., Tang C.Y., Peled J., Gudbjartsson H., Lu D., Hazlet E.A., Downhill J., Haznedar M., Fallon J.H., Atlas S.W. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. NeuroReport 1998, 9:425-430.
13. Chakos M.H., Lieberman J.A., Alvir J., Bilder R., Ashtari M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet 1995, 345:456-457.
14. Chen L., Chen X., Liu W., Wang Q., Jiang T., Wang J., Wang X., Zhou B., Tang J. White matter microstructural abnormalities in patients with late-onset schizophrenia identified by a voxel based diffusion tensor imaging. Psychiatry Research: Neuroimaging 2013, 212:201-207.
15. Cheung V., Chiu C.P.Y., Law C.W., Cheung C., Hui C.L.M., Chan K.K.S., Sham P.C., Deng M.Y., Tai K.S., Khong P.L., McAlonan G.M., Chua S.E., Chen E. Positive symptoms and white matter microstructure in never-medicated first episode schizophrenia. Psychological Medicine 2011, 41:1709-1719.
16. Cohen R.M., Nordahl T.E., Semple W.E., Andreason P, Litman R.E., Pickar D. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. Archives of General Psychiatry 1997, 54:481-486.
17. Corapcioglu, A., Aydemir, O., Yildiz, M., Esen, A., Koroglu, E., 1999. DSM-IV Eksen 1 bozukluklari{dotless} için yapi{dotless}landi{dotless}ri{dotless}lmi{dotless}ş klinik görüşme (SCID), Klinik versiyon. Ankara: Hekimler Yayi{dotless}n Birliǧi.
18. Critchlow H.M., Maycox P.R., Skepper J.N., Krylova O. Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons. Molecular and Cellular Neuroscience 2006, 32:356-365.
19. Dracheva S., Davis K.L., Chin B., Woo D.A., Schmeidler J., Haroutunian V. Myelin-associated mRNA and protein expression deficits in the cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiology of Disease 2006, 21:531-540.
20. Duffau H., Gatignol P., Mandonnet E., Peruzzi P., Tzourio-Mazoyer N., Capelle L. New insights into the anatomo-functional connectivity of the semantic system: a study using corticosubcortical electrostimulations. Brain 2005, 128:797-810.
21. Ellison-Wright I., Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophrenia Research 2009, 108:3-10.
22. Ertugrul A., Salanci B., Basar K., Oguz K., Demir B., Ergun E., Senturk S., Erbas B., Cila A., Ulug B. The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: relationship with treatment response. Psychiatry Research: Neuroimaging 2009, 174:121-129.
23. First M.B. User[U+05F3]s Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I: Clinician Version 1997, American Psychiatric Publishing, Washington, DC.
24. Fitzsimmons J., Kubicki M., Smith K., Bushell G., Estepar San Jose, Westin R., Niznikiewicz C.F., Kikinis M.A., McCarley R., Shenton, M.E.R.W. Diffusion tractography of the fornix in schizophrenia. Schizophrenia Research 2009, 107:39-46.
25. Foong J., Maier M., Clark C.A., Barker G.J., Miller D.H., Ron M.A. Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. Journal of Neurology, Neurosurgery and Psychiatry 2000, 68:242-244.
26. Foong J., Symms M.R., Barker G.J., Miller D.H., Ron M.A. Investigating regional white matter in schizophrenia using diffusion tensor imaging. NeuroReport 2002, 13:333-336.
27. Garver D.L., Holcomb J.A., Christensen J.D. Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. The International Journal of Neuropsychopharmacology 2008, 11:49-61.
28. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:4746-4751.
29. Henze R., Brunner R., Thiemann U., Parzer P., Klein J., Resch F., Stieltjes B. White matter alterations in the corpus callosum of adolescents with first-admission schizophrenia. Neuroscience Letters 2012, 513:178-182.
30. Hubl D., Koenig T., Strik W., Federspiel A., Kreis R., Boesch C., Maier S.E., Schroth G., Lovblad K., Dierks T. Pathways that make voices: white matter changes in auditory hallucinations. Archives of General Psychiatry 2004, 61:658-668.
31. Kakeda S., Korogi Y. The efficacy of a voxel-based morphometry on the analysis of imaging in schizophrenia, temporal lobe epilepsy, and Alzheimer[U+05F3]s disease/mild cognitive impairment: a review. Neuroradiology 2010, 52:711-721.
32. Kanaan R.A., Kim J.S., Kaufmann W.E., Pearlson G.D., Barker G.J., McGuire P.K. Diffusion tensor imaging in schizophrenia. Biological Psychiatry 2005, 58:921-929.
33. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry 1988, 45:789-796.
34. Karlsgodt K.H., Erp T., Poldrack R.A., Bearden C.E., Nuechterlein K.H., Cannon T.D. Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia. Biological Psychiatry 2008, 63:512-518.
35. Kay S.R., Fiszbern A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
36. Konrad A., Winterer G. Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?. Schizophrenia Bulletin 2008, 34:72-92.
37. Konradi C., Heckers S. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biological Psychiatry 2001, 50:729-742.
38. Kostakoglu E., Batur S., Tiryaki A., Gogus A. Pozitif ve Negatif Sendrom Ölçeǧinin (PANSS) Türkçe uyarlamasi{dotless}ni{dotless}n geçerlilik güvenilirliǧi. Türk Psikoloji Dergisi 1999, 14:23-32.
39. Kubicki M., McCarley R., Westin C.F., Park H.J., Maier S., Kikinis R., Jolesz F.A., Shenton M.E. A review of diffusion tensor imaging studies in schizophrenia. Jounal of Psychiatric Research 2007, 41:15-30.
40. Kubicki M., Park H., Westin C.F., Nestor P.G., Mulkern R.V., Maier S.E., Niznikiewicz M., Connor E.E., Levitt J.J., Frumin M., Kikinis R., Jolesz F.A., McCarley R.W., Shenton M.E. DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage 2005, 26:1109-1118.
41. Kuroki N., Kubicki M., Nestor P.G., Salisbury D.F., Park H.J., Levitt J.J., Woolston S., Frumin M., Niznikiewicz M., Westin C.F., Maier S.E., McCarley R.W., Shenton M.E. Fornix integrity and hippocampal volume in male schizophrenic patients. Biological Psychiatry 2006, 60:22-31.
42. Lahti A., Holcomb H.H., Weiler M.A., Medoff D.R., Tamminga C.A. Functional effects of antipsychotic drug: comparing clozapine with haloperidol. Biological Psychiatry 2003, 53:601-608.
43. Lahti A.C., Holcomb H.H., Weiler M.A., Medoff D.R., Frey K.N., Hardin M., Tamminga C.A. Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology 2004, 29:171-178.
44. Lee S.H., Kubicki M., Asami T., Seidman L.J., Goldstein J.M., Mesholam-Gately R.I., McCarley R.W., Shenton M.E. Extensive white matter abnormalities in patients with first-episode schizophrenia: a diffusion tensor imaging (DTI) study. Schizophrenia Research 2013, 143:231-238.
45. Lezak M.D. Neuropsychological Assessment 1995, Oxford University Press, New York. 3rd edition.
46. Liu X., Lai Y., Wang X., Hao C., Chen L., Zhou Z., Yu X., Hong N. Reduced white matter integrity and cognitive deficit in never-medicated chronic schizophrenia:a diffusion tensor study using TBSS. Behavioral Brain Research 2013, 252:157-163.
47. Lu X.H., Dwyer D. Second generation antipsychotic drugs, olanzapine quetiapine and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK and pertusis toxin sensitive pathways. Journal of Molecular Neuroscience 2005, 27:43-64.
48. MacDonald M.L., Eaton M.E., Dudman J.T., Konradi C. Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. Biological Psychiatry 2005, 57:1041-1051.
49. Machado A.M.C. Multiple testing correction in medical image analysis. Journal of Mathematical Imaging and Vision 2007, 29:107-117.
50. Magnotta V.A., Adix M.L., Caprahan A., Lim K., Gollub R., Andreasen N.C. Investigating connectivity between the cerebellum and thalamus inschizophrenia using diffusion tensor tractography: a pilot study. Psychiatry Research: Neuroimaging 2008, 163:193-200.
51. Mandl R.C., Schnack H.G., Luigjes J., van den Heuvel M.P., Cahn W., Kahn R.S., Hulshoff Pol H.E. Tract-based analysis of magnetization transfer ratio and diffusion tensor imaging of the frontal and fronto-temporal connections in schizophrenia. Schiophrenia Bulletin 2010, 36:778-787.
52. Martino J., Brogna C., Robles S.G., Vergani F., Duffau H. Anatomic dissection of the inferior fronto-occipital fasciculus revisited in the lights of brain stimulation data. Cortex 2010, 46:691-699.
53. McEvoy J.P., Lieberman J.A., Stroup T.S., Davis S.M., Meltzer H.Y., Rosenheck R.A., Swartz M.S., Perkins D.O., Keefe R.S., Davis C.E., Severe J., Hsiao J.K. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry 2006, 163:600-610.
54. Melonakos E.D., Shenton M.E., Rathi Y., Terry D.P., Bouix S., Kubicki M. Voxel-based morphometry (VBM) studies in schizophrenia-can white matter changes be reliably detected with VBM?. Psychiatry Research: Neuroimaging 2011, 193:65-70.
55. Meyer-Lindenberg A.S., Olsen R.K., Kohn P.D., Brown T., Egan M.F., Weinberger D.R., Berman K.F. Regionally specific disturbance of dorsolateral prefrontal hippocampal functional connectivity in schizophrenia. Archives of General Psychiatry 2005, 62:379-386.
56. Meyer-Lindenberg A. Neuroimaging and the question of neurodegeneration in schizophrenia. Progress in Neurobiology 2011, 95:514-516.
57. Minami T., Nobuhara K., Okugawa G., Takase K., Yoshida T., Sawada S., Ha-Kawa S., Ikeda K., Kinoshita T. Diffusion tensor magnetic resonance imaging of disruption of regional white matter in schizophrenia. Neuropsychobiology 2003, 47:141-145.
58. Mitelman S.A., Newmark R.E., Torosjan Y., Chu K., Brickman A.M., Haznedar M.M., Hazlett E.A., Tang C.Y., Shihabuddin L., Buchsbaum M.S. White matter fractional anisotropy and outcome in schizophrenia. Schizophrenia Research 2006, 87:138-159.
59. Mitelman S.A., Canfield E.L., Newmark R.E., Brickman A.M., Torosjan Y., Chu K, Hazlett E.A., Haznedar M.M, Shihabuddin L., Buchsbaum M.S. Longitudinal assessment of gray and white matter in chronic schizophrenia: a combined diffusion tensor and structural magnetic resonance imaging study. The Open Neuroimaging Journal 2009, 3:31-47.
60. Mitelman S.A., Nikiforova Y.K., Canfield E.L., Hazlett E.A., Brickman A.M., Shihabuddin L., Buchsbaum M.S. A longitudinal study of the corpus collosum in chronic schizophrenia. Schizophrenia Research 2009, 114:144-153.
61. Molina Rodríguez V., Montz Andreé R., Pérez Castejón M.J., Capdevila García E., Carreras Delgado J.L., Rubia Vila F.J. SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine. American Journal of Psychiatry 1996, 153:1343-1346.
62. Mori T., Ohnishi T., Hashimoto R., Nemoto K., Moriguchi Y., Noguchi H., Nakabayashi T., Hori H., Harada S., Saitoh O., Matsuda H., Kunugi H. Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Research: Neuroimaging 2007, 154:133-145.
63. Nakamura K., Kawasaki Y., Takahashi T., Furuichi A., Noguchi K., Seto H, Suzuki M. Reduced white matter fractional anisotropy and clinical symptoms in schizophrenia: a voxel-based diffusion tensor imaging study. Psychiatry Research: Neuroimaging 2012, 202:233-238.
64. Okugawa G., Nobuhara K., Minami T., Tamagaki C., Takase K., Sugimoto T., Sawada S., Kinoshita T. Subtle disruption of the middle cerebellar peduncles in patients with schizophrenia. Neuropsychobiology 2004, 50:119-123.
65. Okugawa G., Nobuhara K., Sugimoto T., Kinoshita T. Diffusion tensor imaging study of the middle cerebellar peduncles in patients with schizophrenia. Cerebellum 2005, 4:123-127.
66. Okugawa G., Nobuhara K., Minami T., Takase K., Sugimoto T., Saito Y., Yoshimura M., Kinoshita T. Neural disorganization in the superior cerebellar peduncle and cognitive abnormality in patients with schizophrenia: a diffusion tensor imaging study. Progress in Neuropsychophamacology and Biological Psychiatry 2006, 30:1408-1412.
67. Ozdemir Rezaki H., Ertugrul A., Basar K., Saka E. Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice. Progress in Neuropsychopharmacology and Biological Psychiatry 2012, 39:62-68.
68. Peters B.D., Blaas J., de Haan L. Diffusion tensor imaging in th early phase of schizophrenia: what have we learned?. Journal of Psychiatric Research 2010, 44:993-1004.
69. Price G., Cercignani M., Parker G.J.M., Altmann D.R., Barnes T.R.E., Barker G.J., Joyce E.M., Ron M.A. White matter tracts in first-episode psychosis: a DTI tractography study of the uncinate fasciculus. Neuroimage 2008, 39:949-955.
70. Roalf D.R., Ruparel K., Verma R., Elliott M.A., Gur R.E., Gur R.C. White matter organization and neurocognitive performance variability in schizophrenia. Schizophrenia Research 2013, 143:172-178.
71. Rosenheck R, Evans D., Herz L., Cramer J., Xu W., Thomas J., Henderson W., Charney D. How long to wait for a response to clozapine: a comparison of time course and conventional antipsychotic medication in refractory schizophrenia. Schizophrenia Bulletin 1999, 25:709-719.
72. Rotarska-Jagiela A., Oertel-Knoechel V., DeMartino F., Ven V., Formisano E., Roebroeck A., Haenschel C., Hendler T., Maurer K., Vogeley K., Linden D.E. Anatomical brain connectivity and positive symptoms of schizophrenia: a diffusion tensor imaging study. Psychiatry Research: Neuroimaging 2009, 174:9-16.
73. Seal M., Yücel M., Fornito A., Wood S.J., Harrison B.J., Walterfang M., Pell G.S., Pantelis C. Abnormal white matter microstructure in schizophrenia: a voxelwise nalysis of axial and radial diffusivity. Schizophrenia Research 2008, 101:106-110.
74. Shergill S., Kanan R.A., Chitnis X.A., O'Daly O., Jones D.K., Frangou S., Williams S.C., Howard R.J., Barker G.J., Murray R.M., McGuire P. Diffusion tensor imaging study of fasciculi in schizophrenia. American Journal of Psychiatry 2007, 164:467-473.
75. Skelly L.R., Calhoun V., Meda S.A., Kim J., Mathalon D.H., Pearlson G.D. Diffusion tensor imaging in schizophrenia: relationship to symptoms. Schizophrenia Research 2008, 98:157-162.
76. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., Watkins K.E., Ciccarelli O., Cader M.Z., Matthews P.M., Behrens T.E. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006, 31:1487-1505.
77. Spreen O., Strauss E.A. Compendium of Neuropsychological Tests: Administration, Norms, and Commentary 1998, University Press, New York.
78. Sugai T., Kawamura M., Iritani S., Araki K., Makifuchi T., Imai C., Nakamura R., Kakita A., Takahashi H., Nawa H. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Annals of the New York Academy of Sciences 2004, 1025:84-91.
79. Sugranyes G., Kyriakopoulos M., Dima D., O'Muircheartaigh J., Corrigall R., Pendelbury G., Hayes D., Calhoun V.D., Frangou S. Multimodal analyses identify linked functional and white matter abnormalities within the working memory network in schizophrenia. Schizophrenia Research 2012, 138:136-142.
80. Sun Z., Wang F., Cui L., Breeze J., Du X., Wang X., Cong Z., Zhang H., Li B., Hong N., Zhang D. Abnormal anterior cingulum in patients with schizophrenia: a diffusion tensor imaging study. NeuroReport 2003, 14:1833-1836.
81. Takei K., Yamasue H., Abe O., Yamada H., Inoue H., Suga M., Muroi M., Sasaki H., Aoki S., Kasai K. Structural disruption of the dorsal cingulum bundle is associated with impaired Stroop performance in patients with schizophrenia. Schizophrenia Research 2009, 114:119-127.
82. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
83. Wang Q, Cheung C., Deng W., Li M., Huang C., Ma X., Wang Y., Jiang L., Sham P.C., Collier D.A., Gong Q., Chua S.E., McAlonan G.M., Li T. White matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment. Psychological Medicine 2013, 43:2301-2309.
84. Wechsler D. The Wechsler Memory Scale-Revised 1987, The Psychological Coporation, Harcourt Brace Jovanovic, Inc, New York.
85. Wotanis J., Hanak S.E., Wettstein J.G., Black M.D. Comparative analysis of acute and chronic administration of haloperidol and clozapine using [3H] 2-deoxyglucose metabolic mapping. Schizophrenia Research 2003, 61:195-205.
86. Xu H., Yang H.J., Zhang Y., Clough R., Browning R., Li X.M. Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone. Behavioral Neuroscience 2009, 123:418-429.
87. Xu H., Yang H.J., McConomy B., Browning R., Li X.M. Behavioral and neurobiological changes in C57BL/6 mouseexposed to cuprizone: effects of antipsychotics. Frontiers in Behavioral Neuroscience 2010, 4:8.